NASDAQ:AIPT - Precision Therapeutics News Headlines Sign in or create an account to add this stock to your watchlist. Get Started $0.85 +0.02 (+2.41 %) (As of 03/21/2019 08:56 AM ET)Previous Close$0.8315Today's Range$0.83 - $0.8752-Week Range$0.60 - $1.58Volume49,095 shsAverage Volume70,876 shsMarket Capitalization$12.19 millionP/E RatioN/ADividend YieldN/ABeta2.07 ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Headlines Precision Therapeutics (NASDAQ AIPT) News Headlines Source: All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance DateHeadlinePrecision Therapeutics Incwww.bloomberg.com - March 19 at 12:04 PMPrecision Therapeutics Extends Exchange Offer for Helomics Notes and Warrantsfinance.yahoo.com - March 14 at 12:06 PMHead to Head Comparison: Precision Therapeutics (AIPT) and Wound Management Technologies (WNDM)www.americanbankingnews.com - March 7 at 9:21 PMCompany Concluded 2018 With 38 Percent Increase in STREAMWAY System Disposablesglobenewswire.com - March 6 at 4:10 PMHistogenics (HSGX) and Precision Therapeutics (AIPT) Financial Contrastwww.americanbankingnews.com - March 6 at 3:32 PMSarepta Therapeutics Announces Pricing of $375.0 Million Public Offering of Common Stock - GlobeNewswireglobenewswire.com - March 6 at 11:35 AMPrecision Therapeutics’ Skyline Medical Division Captures Market Share in Saudi Arabia Via New Orders While Disposable Sales Show Significant Year-Over-Year Increasefinance.yahoo.com - March 5 at 9:59 AMDawson James Securities Announces the Closing of Public Offering for Precision Therapeutics Inc.finance.yahoo.com - March 1 at 4:01 PMHistogenics (HSGX) and Precision Therapeutics (AIPT) Critical Reviewwww.americanbankingnews.com - February 27 at 7:20 PMPrecision Therapeutics Inc. Announces Proposed Public Offering of Securitiesfinance.yahoo.com - February 27 at 11:55 AMPrecision Therapeutics Inc. Announces Pricing of Public Offering of Up to $1.26 Million of Unitsfinance.yahoo.com - February 27 at 11:55 AMPrecision Therapeutics Inc. is Excited to Announce a Special Meeting of Stockholders and Commencement of Registered Exchange Offerfinance.yahoo.com - February 19 at 12:03 PMRL, BOX among premarket gainersseekingalpha.com - February 5 at 10:10 AMPrecision Therapeutics’ TumorGenesis Division Isolates Discovery Biomarkers for Thyroid Cancer Cellwww.nasdaq.com - February 5 at 10:10 AMPrecision Therapeutics’ TumorGenesis Division Isolates Discovery Biomarkers for Thyroid Cancer Cell Types, Initiating Its Proprietary Process for New Drug Development Via Patient-Derived Tumor Modelsfinance.yahoo.com - February 5 at 10:10 AMPrecision establishes Streamway distribution in Taiwanseekingalpha.com - January 25 at 11:06 AMPrecision Therapeutics Has Groundbreaking Approach to Personalized Cancer Treatment, Reports CEOCFO Magazinefinance.yahoo.com - January 22 at 10:58 AMPrecision Therapeutics' CEO invests $1.4M; shares up 3% premarketseekingalpha.com - January 20 at 8:56 PMPrecision Therapeutics CEO invests another $1M; shares up 3% premarketseekingalpha.com - January 18 at 9:47 AMPrecision Therapeutics Receives $1,370,000 Investment from CEO and Director, Carl Schwartzfinance.yahoo.com - January 18 at 9:47 AMLarge Sale to Prestigious Health System Further Validates STREAMLINE Utilityglobenewswire.com - January 17 at 1:05 PMPrecision Therapeutics’ Skyline Medical Division Significantly Expands Footprint in New England With Sale of Six STREAMWAY Systems to Yale University Ambulatory Outpatient Surgical Centerfinance.yahoo.com - January 17 at 1:05 PMPrecision Therapeutics Inc. (AIPT) CEO Dr. Carl Schwartz on Q3 2018 Results - Earnings Call Transcriptseekingalpha.com - November 17 at 10:16 AMPrecision Therapeutics Reports Third Quarter 2018 Financial Resultsfinance.yahoo.com - November 15 at 10:39 AMHelomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian Cancerfinance.yahoo.com - November 14 at 10:16 AMPrecision Therapeutics to Hold Business Update Conference Call on November 14, 2018finance.yahoo.com - November 8 at 10:44 AMBRIEF-Precision Therapeutics Secures Rights To Novel Technology Designed To Develop Cancer Drugswww.msn.com - November 7 at 10:59 AMPrecision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its Mutationfinance.yahoo.com - November 7 at 10:59 AMPrecision Therapeutics’ CEO Talks with Uptick Newswire’s Stock Day Podcast About Exciting New Breakthroughs in Tumor Treatment and What’s on the Horizonfinance.yahoo.com - November 5 at 3:31 PMFiling under Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Precision Therapeutics Inc.: SEC File Nos. 001-36790; and 333-221966feeds.benzinga.com - October 29 at 10:10 PMPrecision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhDfinance.yahoo.com - October 11 at 10:00 AMPrecision Therapeutics sells first Streamway in Europe; shares up 9%seekingalpha.com - September 27 at 11:58 AMPrecision Therapeutics Secures First STREAMWAY System Sale in Europefinance.yahoo.com - September 27 at 11:58 AMDr. Bob Murphy, Head of Computational Biology at Carnegie Mellon University, Joins Precision Therapeutics’ Scientific Advisory Boardfinance.yahoo.com - September 26 at 10:54 AMPrecision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Boardfinance.yahoo.com - September 11 at 10:56 AMPrecision Therapeutics Forms Scientific Advisory Board to Advance its Strategy in the Precision Medicine Sectorfinance.yahoo.com - September 6 at 11:00 AMPrecision Therapeutics Inc. (AIPT) CEO Carl Schwartz on Q2 2018 Results - Earnings Call Transcriptseekingalpha.com - August 15 at 10:43 AMPrecision Therapeutics Investee, Helomics Corporation, Announces Commercial Launch of New ‘HelomicsDiscover’ Program to Drive Forward the Next Generation of Precision Cancer Therapiesfinance.yahoo.com - August 14 at 11:01 AMPrecision Therapeutics to Hold Business Update Conference Call on August 14, 2018finance.yahoo.com - August 9 at 11:00 AMPrecision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights Platformfinance.yahoo.com - August 9 at 11:00 AMPrecision Therapeutics Making Rapid Progress with Both Personalized Medicine and Unique Medical Waste Disposal Systemfinance.yahoo.com - August 7 at 3:26 PMGerman Stock Exchange approves delisting request of Precision Therapeuticsseekingalpha.com - August 2 at 11:17 AMPrecision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment Strategiesfinance.yahoo.com - July 17 at 3:24 PMPrecision Therapeutics nabs European patent covering Streamway; shares up 10%seekingalpha.com - July 14 at 5:45 PMPrecision Therapeutics Inc. (AIPT) Secures European Patent for STREAMWAY System Covering Automated, Direct-to-Drain Medical Fluid Disposalwww.streetinsider.com - July 14 at 5:45 PMPrecision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal Systemfeeds.benzinga.com - July 12 at 8:09 PMPrecision Therapeutics Signs Definitive Merger Agreement with Helomics Holding Corporationfeeds.benzinga.com - June 28 at 8:16 PMPrecision Therapeutics Launches New Websitefinance.yahoo.com - May 31 at 9:09 AMPrecision Therapeutics' (AIPT) CEO Carl Schwartz on Q1 2018 Results - Earnings Call Transcriptseekingalpha.com - May 16 at 8:40 AMPrecision Therapeutics Reports First Quarter 2018 Financial Resultsfinance.yahoo.com - May 16 at 8:40 AM This page was last updated on 3/21/2019 by MarketBeat.com StaffFeatured Article: What is the Coverage Ratio?